Deals - Page 15
Paul Hastings, Freshfields and Addleshaws lead on Coventry Building Society’s £780m Co-op Bank acquisition
Deal to create lender with £89bn balance sheet and nearly five million customers
Complex global M&A deals face increased merger clearance challenges, study finds
Some 43% of cross-border transactions over the past four years failed to close due to regulatory scrutiny
Goodwin, Covington shepherd Biogen’s $1.8bn acquisition of rare disease drugmaker
Covington counsels Biogen as Goodwin reps acquisition target Human Immunobiology Biosciences
Latham, Kirkland shepherd CyberArk’s $1.5bn Venafi acquisition
Latham guides CyberArk in acquisition of cybersecurity business from Kirkland-repped Thoma Bravo
Latham, Skadden and Paul Weiss among firms advising on $6.9bn Squarespace take private
Private equity firm Permira is leading the deal, with support from General Atlantic and Accel
Greenberg, Goodwin shepherd Ono Pharma’s $2.4bn Deciphera acquisition
Greenberg counsels Ono in deal to expand Japanese group’s oncology portfolio and US presence
Kirkland, Latham shepherd Thoma Bravo’s £4.3bn Darktrace acquisition
Kirkland acts for marquee client Thoma Bravo as Latham counsels UK-listed cyber security company
Reed Smith, Shoosmiths lead on Concord’s £1.1bn Hipgnosis takeover
DLA Piper and Latham also called in for deal to save embattled song fund
Paul Hastings, Weil called in for sale of majority stake in Edinburgh Airport
Paul Hastings acts for buyer Vinci in £1.27bn deal as Weil counsels seller Global Infrastructure Partners
Skadden, Slaughter and May lead on International Paper’s £5.8bn DS Smith acquisition
Deal sees Skadden-repped International Paper beat earlier offer from British rival Mondi
Freshfields, Fenwick & West advise on Johnson & Johnson’s $13.1bn acquisition of Shockwave
Purchase of heart tech-maker Shockwave Medical is latest in series of deals to bolster J&J’s cardiac health division
Skadden tops M&A league rankings in first quarter as deal value rebounds
Wachtell and Paul Weiss follow closely behind as megadeals contribute to 38% rise in global deal value
Paul Hastings advises on Trump-linked Truth Social SPAC merger
Nelson Mullins also advised on the deal, which propelled the value of Trump’s Truth Social stake to $4.6bn
Freshfields, Goodwin lead on AstraZeneca’s $2bn acquisition of Fusion Pharma
Deal second this month to see Freshfields advise acquisitive AstraZeneca
Kirkland, Latham shepherd EQT’s $35bn Equitrans gas merger
Last year’s top M&A firms lead as flurry of US oil and gas dealmaking continues